Deborah R Barnbaum

Biographic Data

ID6501754
NAMEDeborah R Barnbaum
GIVEN NAMESDeborah R
FAMILY NAMEBarnbaum
SIGNATUREBARNBAUM D R
AFFILIATIONSKent State University
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2000
LATEST PUBLICATION YEAR2004
H-INDEX0

  • Bioethics , Ellen Frankel Paul, Fred D. Miller, Jr, and Jeffrey Paul, editors

    Deborah R BarnbaumARTICLEPolitics and the Life Sciences2004

  • "Making More Sense of "Minimal Risk

    Deborah R Barnbaum, Deborah BarnbaumARTICLEIRB Ethics and Human Research2002

    Some clarification is required to understand this definition. First, it should be clear that risk and harm are not the same concepts. Beauchamp and Childress note that harm is the normatively neutral sense of thwarting, defeating, or setting back the interests of one party by causes that include self-harming conditions as well as the (intentional or unintentional) actions of another party.3 Thus though they may not be bad in an absolute sense, ha…

  • The FDA's Proposal for Public Disclosure of Adverse Events in Gene Therapy Trials

    Open AccessDeborah R BarnbaumARTICLEPolitics and the Life Sciences2000

    In January 2001, the Food and Drug Administration (FDA) proposed annual public disclosure of adverse events during gene therapy and xenotransplantation trials. The proposed policy raises the following questions: (1) Is the reformed policy in accord with the FDA's long-standing informed consent policies? (2) Why pair gene therapy trials and xenotransplantation trials in the revised guidelines? (3) Why single out these trials for public disclosure …